Literature DB >> 1914546

Pleural fluid analysis in malignant mesothelioma. Prognostic implications.

A Gottehrer1, D A Taryle, C E Reed, S A Sahn.   

Abstract

Pleural fluid characteristics of 26 patients diagnosed with malignant mesothelioma over an 18-year period were reviewed and compared with those of patients with effusions due to other malignancies. Survival from time of initial thoracentesis was directly correlated with pleural pH and decreased pleural fluid/serum glucose ratios but was not related to protein or LDH concentration. Decreased pleural fluid pH was statistically related to a decreased pleural fluid/serum glucose ratio. Patients with low pH (less than 7.30) pleural effusions had statistically decreased mean survival and decreased mean pleural fluid/serum glucose ratios compared with patients with normal pH (greater than or equal to 7.30). Patients with malignant mesothelioma pleural effusions had statistically decreased mean pleural fluid pH compared with patients with other malignant pleural effusions. Decreased levels of pleural fluid pH and pleural fluid/serum glucose ratios have negative prognostic significance and probably correlate with the degree of tumor bulk affecting the pleural surface.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914546     DOI: 10.1378/chest.100.4.1003

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Pleural fluid findings as prognostic factors for malignant pleural mesothelioma.

Authors:  Tanseli Efeoglu Gonlugur; Ugur Gonlugur
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

2.  An update in the management of malignant pleural effusion.

Authors:  Dk Muduly; Svs Deo; Ts Subi; Aa Kallianpur; Nk Shukla
Journal:  Indian J Palliat Care       Date:  2011-05

3.  Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes.

Authors:  Justin W Ady; Snider Desir; Venugopal Thayanithy; Rachel I Vogel; André L Moreira; Robert J Downey; Yuman Fong; Katia Manova-Todorova; Malcolm A S Moore; Emil Lou
Journal:  Front Physiol       Date:  2014-10-31       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.